Diabetic patients with ideal blood sugar control can take aminoglycan chondroitin, which is a very good drug that mainly treats joint cartilage diseases, such as damage to joints or osteophytes. It can repair the cartilage surface of the joints well, which is conducive to the recovery of joint cartilage, and the effect of clinical application is also very good. The sugar content of amylose chondroitin is very low and basically does not affect the blood sugar of diabetic patients. However, in clinical practice, it is better for diabetic patients to control fasting blood sugar at 6.0mmol/L and blood sugar not exceeding 8.0mmol/L 2 hours after meal, so that the effect of applying amylose chondroitin will be better.